PureTech Health Plc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About PureTech Health Plc
PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.
Frequently asked questions
To buy PureTech Health Plc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for PureTech Health Plc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for PureTech Health Plc is PRTC:xlon. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
PureTech Health Plc has its primary listing on London Stock Exchange. You can trade PureTech Health Plc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, PureTech Health Plc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include PureTech Health Plc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like PureTech Health Plc.